Locations
United States · Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2014
Selux Diagnostics is a Boston-based company focused on precision diagnostics for infectious diseases, specifically through their innovative Selux Next Generation Phenotyping (NGP) System. This system revolutionizes antibiotic susceptibility testing (AST) by providing rapid, accurate results that help combat antibiotic resistance, a growing global health crisis. By offering a comprehensive menu of testing options and updated breakpoints, Selux aims to optimize treatment decisions and improve patient outcomes. Their technology addresses the limitations of traditional AST systems, making it a critical tool for healthcare providers in managing infectious diseases effectively. With a commitment to preserving the efficacy of antibiotics, Selux is positioned as a leader in the diagnostics market, addressing urgent healthcare needs.
Something looks off?On-site & Remote